(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
1997 Medical Policy StatementML20217G031 |
Person / Time |
---|
Issue date: |
09/30/1997 |
---|
From: |
NRC |
---|
To: |
|
---|
References |
---|
RULE-PR-35-MISC NUDOCS 9710090156 |
Download: ML20217G031 (5) |
|
Similar Documents from NRC |
---|
Category:NRC TECHNICAL REPORT
MONTHYEARML20203D0991999-09-18018 September 1999 Integrated Materials Performance Evaluation Program Review of Maine Agreement State Program, 980915-18 ML20211G9151999-08-31031 August 1999 External Regulation of Department of Energy Nuclear Facilities.A Pilot Program ML20212M2271999-08-31031 August 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of Nrc ML20217K6091999-08-30030 August 1999 Draft Rept, Integrated Materials Performance Evaluation Program Review of Washington Agreement State Program, 990830-0903 ML20217G3201999-08-17017 August 1999 Draft, Integrated Materials Performance Evaluation Program Review of Iowa Agreement State Program, for 990817-20 ML20217L8271999-08-17017 August 1999 Proposed Final Rept, Integrated Materials Performance Evaluation Program Review of Iowa Agreement State Program, 990817-20 ML20212M2331999-08-0303 August 1999 Staff Response to Tasking Memorandum & Stakeholder Concerns, as of 990803 ML20211F4771999-07-31031 July 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of Nrc ML20217M9361999-07-31031 July 1999 Nuclear Regulatory Commission 1998 Annual Report ML20210R2011999-07-16016 July 1999 Draft Rept, Integrated Materials Performance Evaluation Program Review of South Carolina Agreement State Program 990712-16 ML20216E0011999-07-13013 July 1999 Final Rept, Impep Review of North Dakota Agreement State Program,990413-16 ML20210H6911999-07-0606 July 1999 Final Rept Impep Review of Maryland Agreement State Program,990322-26 ML20211F4921999-07-0202 July 1999 Staff Response to Tasking Memorandum & Stakeholder Concerns as of 990702 ML20216D8901999-06-30030 June 1999 IPEEEs Technical Evaluation Rept High Winds,Floods & Other External Events ML20210L4731999-06-30030 June 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of USNRC, Dtd June 1999 ML20196K3791999-06-30030 June 1999 Annual Rept on Effectiveness of Training in Nuclear Industry for Cy 1998 ML20195K4001999-06-16016 June 1999 Draft Technical Study of SFP Accidents for Decommissioning Plants ML20210K0441999-06-15015 June 1999 Draft Rept Impep Follow-up Review of Kansas Radiation Control Program on 990615-17 ML20212K0161999-06-15015 June 1999 Final Rept, Integrated Materials Performance Evaluation Program (Impep) Follow-Up Review of Kansas Radiation Control Program ML20210L4891999-06-0202 June 1999 Staff Response to Tasking Memo & Stakeholder Concerns, as of 990602 ML20209F7421999-05-31031 May 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of Usnrc ML20207A2961999-05-19019 May 1999 Integrated Materials Performance Evaluation Program Review of Region III Materials Program, 990315-19,proposed Final Rept ML20206Q9751999-05-10010 May 1999 Draft Rept, Integrated Materials Performance Evaluation Program Review of North Dakota Agreement State Program, 990413-16 ML20209G1931999-05-0303 May 1999 Staff Response to Tasking Memo & Stakeholder Concerns as of May 3 1999 ML20195B7861999-04-30030 April 1999 TER for Proposed Remedial Action at Naturity Uranium Mill Tailings Site Naturita,Co ML20207C0411999-04-30030 April 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of Us Nrc ML20210R5421999-04-28028 April 1999 Final Rept, Integrated Materials Performance Evaluation Program (Impep) Follow-Up Review of New York City Radiation Control Program ML20206B5101999-04-0707 April 1999 Draft Supporting Statement for 10CFR26 Fitness-For-Duty Program ML20207C0571999-04-0505 April 1999 Staff Response to Tasking Memo & Stakeholder Concerns as of 990405 ML20205P1421999-03-31031 March 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of NRC, Mar 1999 ML20209A6511999-03-22022 March 1999 Proposed Final Rept Integrated Matls Performance Evaluation Program,Review of Maryland Agreement State Program ML20205S1811999-03-19019 March 1999 Draft Integrated Matls Performance Evaluation Program Review of Region III Matls Program 990315-19 ML20204F2121999-03-19019 March 1999 Draft Rept Integrated Matl Performance Evaluation Program Review of Florida Agreement State Program, 990222-26 ML20195J6111999-03-15015 March 1999 Final Rept, Integrated Matls Performance Evaluation Program Review of Region III Matls Program,990315-19 ML20205M7441999-03-12012 March 1999 Rept of Review,Allegations of Discrimination in NRC Ofc of Investigations Cases 1-96-002,1-96-007 & 1-97-007, & Associated Lessons Learned ML20205P1591999-03-0505 March 1999 Staff Response to Tasking Memo & Stakeholder Concerns as of 990305 ML20207M8921999-02-28028 February 1999 Monthly Status Rept on Licensing Activitives & Regulatory Duties of NRC, February 1999 ML20206Q9991999-02-22022 February 1999 Proposed Final Rept, Integrated Materials Performance Evaluation Program Review of Florida Agreement State Program, 990222-26 ML20195G9241999-02-22022 February 1999 Final Rept Integrated Materials Performance Evaluation Program Review of Florida Agreement State Program, 990222- 26 ML20207M9031999-02-0808 February 1999 Staff Response to Tasking Memo & Stakeholder Concerns, as of 990208 ML20205F0911999-02-0202 February 1999 Comparison of Us Reactor Regulation Programs with That of France,Japan & Uk ML20203A2901999-01-31031 January 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of Nrc ML20206Q6261999-01-15015 January 1999 Ad Hoc Review Panel Rept on Differing Professional Opinion of F Burrows ML20205L0031999-01-12012 January 1999 Integrated Assessment of Training Needs for Reactor Projects Staff ML20198N5831998-12-31031 December 1998 Monthly Status Rept on Licensing Activities & Regulatory Duties of Usnrc ML20209F4281998-12-21021 December 1998 Differing Professional View Panel Rept Concerning Handling of Liquid Effluent Releases from in Situ Leach Operations at Licensed U Recovery Facilities ML20198N6181998-12-0101 December 1998 Staff Response to Tasking Memo & Stakeholder Concerns,As of 981201 ML20196K1511998-11-30030 November 1998 Revised Final Rept, Integrated Matls Performance Evaluation Program Review of New York Agreement State Program, for Period 980126-0424 ML20198P3451998-11-29029 November 1998 Draft of Incident Response Function Self-Assessment Rept ML20202C8821998-11-20020 November 1998 Proposed Final Rept, Integrated Matls Performance Evaluation Program Review of Utah Agreement State Program, 981116-20 1999-09-18
[Table view]Some use of "" in your query was not closed by a matching "". Category:TEXT-SAFETY REPORT
MONTHYEARML20217M1641999-10-19019 October 1999 Safeguards Evaluation Rept Accepting Amend 29 to License SNM-33 for Abb Combustion Engineering Nuclear Power,Inc ML20217N1731999-10-0808 October 1999 Safeguards Evaluation Rept Approving Amend 11 to License SNM-1097 for GE Re Rev 5 to Physical Protection Plan ML20217B3951999-10-0606 October 1999 Compliance Evaluation Rept Supporting Amend 3 to Coc GDP-1 ML20217C3831999-10-0404 October 1999 Safety Evaluation Supporting Amend 60 to License SNM-696 ML20216J4711999-09-29029 September 1999 Safety Evaluation Rept Supporting Amend 36 to License SNM-1168 for Framatome Cogema Fuels ML20203D0991999-09-18018 September 1999 Integrated Materials Performance Evaluation Program Review of Maine Agreement State Program, 980915-18 ML20216E7881999-09-15015 September 1999 Safety Evaluation Supporting Amend 1 to License SNM-0362 ML20211G9151999-08-31031 August 1999 External Regulation of Department of Energy Nuclear Facilities.A Pilot Program ML20212M2271999-08-31031 August 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of Nrc ML20217K6091999-08-30030 August 1999 Draft Rept, Integrated Materials Performance Evaluation Program Review of Washington Agreement State Program, 990830-0903 ML20211B4431999-08-19019 August 1999 SER Accepting Amend 28 to License SNM-33 for Abb Combustion Engineering Nuclear Power,Inc ML20211B4201999-08-19019 August 1999 SER Supporting Amend 10 to License SNM-1097 for GE ML20217G3201999-08-17017 August 1999 Draft, Integrated Materials Performance Evaluation Program Review of Iowa Agreement State Program, for 990817-20 ML20217L8271999-08-17017 August 1999 Proposed Final Rept, Integrated Materials Performance Evaluation Program Review of Iowa Agreement State Program, 990817-20 ML20210T7881999-08-12012 August 1999 Safeguards Evaluation Rept Accepting Amend 58 to License SNM-0696 for General Atomics ML20210T8431999-08-12012 August 1999 Safety Evaluation Supporting Amend 59 to License SNM-0696 ML20210U0091999-08-12012 August 1999 Safety Evaluation Supporting Amend 7 to License SNM-1067 ML20212M2331999-08-0303 August 1999 Staff Response to Tasking Memorandum & Stakeholder Concerns, as of 990803 ML20217M9361999-07-31031 July 1999 Nuclear Regulatory Commission 1998 Annual Report ML20211F4771999-07-31031 July 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of Nrc ML20210L5681999-07-30030 July 1999 SER Accepting Renewed License SNM-142 for Purdue Univ ML20210E9991999-07-23023 July 1999 SER Accepting Amend 57 to License SNM-696 for General Atomics ML20210E9681999-07-23023 July 1999 SER Accepting Amend 17 to License SNM-1227 for Siemens Power Corp ML20210R2011999-07-16016 July 1999 Draft Rept, Integrated Materials Performance Evaluation Program Review of South Carolina Agreement State Program 990712-16 ML20216E0011999-07-13013 July 1999 Final Rept, Impep Review of North Dakota Agreement State Program,990413-16 ML20210H6911999-07-0606 July 1999 Final Rept Impep Review of Maryland Agreement State Program,990322-26 ML20211F4921999-07-0202 July 1999 Staff Response to Tasking Memorandum & Stakeholder Concerns as of 990702 ML20216D8901999-06-30030 June 1999 IPEEEs Technical Evaluation Rept High Winds,Floods & Other External Events ML20196K3791999-06-30030 June 1999 Annual Rept on Effectiveness of Training in Nuclear Industry for Cy 1998 ML20210L4731999-06-30030 June 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of USNRC, Dtd June 1999 ML20212G6821999-06-25025 June 1999 Baseline Insp Program Workshop on 990621-25 in Irving,Tx. with Significance Determination Process Workbook ML20195K4001999-06-16016 June 1999 Draft Technical Study of SFP Accidents for Decommissioning Plants ML20210K0441999-06-15015 June 1999 Draft Rept Impep Follow-up Review of Kansas Radiation Control Program on 990615-17 ML20212K0161999-06-15015 June 1999 Final Rept, Integrated Materials Performance Evaluation Program (Impep) Follow-Up Review of Kansas Radiation Control Program ML20195D3151999-06-0202 June 1999 SER Approving Amend Request Re Changes to Emergency Plan ML20210L4891999-06-0202 June 1999 Staff Response to Tasking Memo & Stakeholder Concerns, as of 990602 ML20195D0281999-06-0202 June 1999 Safeguards Evaluation Rept Approving Request for Time Extension to Rept Results of Physical Inventory ML20209F7421999-05-31031 May 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of Usnrc ML20195B6871999-05-24024 May 1999 Safety Evaluation Supporting Amend 2 to License SNM-986 ML20207A2961999-05-19019 May 1999 Integrated Materials Performance Evaluation Program Review of Region III Materials Program, 990315-19,proposed Final Rept ML20206L5541999-05-11011 May 1999 Safety Evaluation Approving Amend to Include as Authorized Activity,Storage of Moderated Special Nuclear Matl in sea-land Containers Equipped with Storage Grids Fastened to Floor ML20206Q9751999-05-10010 May 1999 Draft Rept, Integrated Materials Performance Evaluation Program Review of North Dakota Agreement State Program, 990413-16 ML20209G1931999-05-0303 May 1999 Staff Response to Tasking Memo & Stakeholder Concerns as of May 3 1999 ML20207C0411999-04-30030 April 1999 Monthly Status Rept on Licensing Activities & Regulatory Duties of Us Nrc ML20195B7861999-04-30030 April 1999 TER for Proposed Remedial Action at Naturity Uranium Mill Tailings Site Naturita,Co ML20210R5421999-04-28028 April 1999 Final Rept, Integrated Materials Performance Evaluation Program (Impep) Follow-Up Review of New York City Radiation Control Program ML20205R2891999-04-12012 April 1999 Safety Evaluation Approving Change to Authorized Use & Place of Use for Matl Specified in Condition 6.H ML20205P5591999-04-0909 April 1999 Safety Evaluation Rept Approving Amend Request Dtd 990312, Re Changes to Mailing Addresses ML20206B5101999-04-0707 April 1999 Draft Supporting Statement for 10CFR26 Fitness-For-Duty Program ML20207C0571999-04-0505 April 1999 Staff Response to Tasking Memo & Stakeholder Concerns as of 990405 1999-09-29
[Table view]Some use of "" in your query was not closed by a matching "". |
Text
__ - _-_ _ __ - -__ _ .
i September 30,1997 I
1 1997 MEDICAL POLICY STATEMENT
! NOTE 1
l l
l Following Commission approval of the staffs program to ravise 10 CFR Part 35 and associated guidance documents, the NRC staff initiated development of draft rule language, using a modality based approach. As directed by the Commission, the staff has developed alternatives, with draft rule text, for the more significant issues associated with the regulation of the medical use of byproduct material. These alternatives to regulation in specific areas are intended to help focus the d!scussion during the NRC's public meetings and the meetings with medical professional societies during the Fall of 1997 and to assist the staff in developing the proposed rule language, i The alternatives represent a broad range of possibilities and are being provided to
. stimulate input from members of the public in an effort to encourage all interested parties to provide input into the development of the revised regulation. The NRC staff has not selected any alternative at this time, and is open to additional alternatives which might be proposed that are consistent with the guidance provided by the Commission.
.. U -\ N 'I /10 0 ice b M b
,1 if, I n
\
h #
?$A 35 MISC lR**' " PDR gggggll31H TA
- W'60
F d
o 0/25/97 RECOMMENDATION FOR REVISION TO NRC'S 1979 MEDICAL POLICY STATEMENT OPTION 1: Status Quo Current statement of general policy to guide regulation of medical ases of radioisot pes states:
- 1. The NRC will continue to regulate the medical uses of radioisotopes as necessary to provide for the radiation safety of workers and the general public. ,
- 2. The NRC w?i regulate the radiation safety of patients where justified by the risk l to patients and where voluntary standarus, or compliance with these standards, ;
are inadequate.
- 3. The NRC will minimize intrusion into medical judgments affecting patients and into other areas traditionally considered to be a part of the practice of medicine.
EIQ1
- 1. Consistent with NRC's authority in the Atomic Energy Act of 1954, as amended, to .
regulate domestically the uses of byproduct material, including medical use, to protect public health and minimize danger to life and property.
2.- Recognizes that physicians have primary responsibility for protection of their patients, by stating that the NRC will minimize intrusion into medical judgments affecting safety.
- 3. Regulation of the radiation safety of patients is risk based.
- 4. For higher risk activities, NRC may elect to circumscribe areas that might otherwise be regarded as within the discretion of the physician.
- 5. Current statement provides for balance between protection of the patient and avoiding intrusion into the practice of medicine.
GQat 1.- Allows for some, although minimal, NRC involvement in medical judgements affecting patients.
~
l
_ . _ . _ _ _..-- _.~- _ _ _. _ __ _ -
4 f
OPTION 2: Apnl 1997 recommendation of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) t ACMUI recommended statement of general policy to guide regulation of medical uses of radioisotopes would be:
- 1. [No change.)
- 2. The NRC will regulate the rad ation safety of patients only where justified by the risk to the patients, and only where voluntary standards or compliance with these standards are inadequate. Assessment of the risks justifying such regulations will reference comparable riska and comparablo modes of regulation for other types of medical practice.
. 3. The NRC will not intrude into rredical judgments affecting patients and into other .
areas traditionally considered to be a part of the practice of medicine. 4 ELDL
, 1. Regulation of the radiation safety of patients is risk based.
" 2. Acceptable level of risk associated with regulating the medical use of byproduct material may be lower than in other areas of mecficine.
~
- 3. Clearly states that NRC will not be involved with the physician patient interface.
l 4. Recognizes that physicians have primary responsibility for protection of their patients.
C0.0A
- 1. Requires NRC to assess risks in other typss of medical practices, which may be j problematic.-
- ' 2. Implementation of statements #2 and #3 could be in conflict when the level of risk justifies intrusion.
k 2
---,v -c, <yo -
m---- g -s m>+ -~v,-- - - - - - ~
ii j - DH.lQft1 l Revised statement of general policy to guide regulation of medical uses oi :adioisotopes would
- be
l 1. (No change.)
l l 2. The NRC will regulate the radiation safety of patients only where justified by the risk to the patients, and only where voluntary standards or compliance with these l standards are inadequate.
. 3. The NRC will continually strive to minimize involvement in medical judgments i affecting patients and into other areas traditionally considered to be a part of the
- practice of medicine.
1 i
l ElQA
- 1. Consistent with NRC's authority in the Atomic Energy Act of 1954, as amended, to j regulate domestically the uses of byproduct material, including medical use, to protect public health and minimize danger to life and property.
- 2. Regulation of the radiation safety of patients is risk based.
4
! 3. For higher risk activities, NRC may elect to circumscribe areas that might otherwise be ,
. regarded as within the discretion of the physician. l
- 4. Recognizes that physicians have primary responsibility for protection of their patients.
S. Provides additional emphasis that NRC's policy is to minimize intrusion into medical
! practice.
l CDDR j 1. Acceptable level of riek associated with regulating the medical use of byproduct material may be lower than for other areas of medicine.
- 2. Allows for some, although minimal, NRC involvement in medical judgements affecting patients.
3
E t'
s QPTION 4:
Revised statement of general policy to guide regulation of medical uses of radioisotopes would be:
- 1. [No change.)
- 2. The NRC will regulate the radiation safety of patients consistent with the risk posed by the rad!eactive materials, in regulating the radiation safety of patients, NRC's role is to assure that the physician's prescription is accurately delivered to the correct patient.
- 3. The NRC will not intrude into the medical judgement forming the basis of the physicians' prescription.
P.19n
- 1. Consistent with NRCs authority in the Atomic Energy Act of 1954, as amended, to regulate domestical., the uses of byproduct material, including medical use, to protect public health and minimize danger to life and property.
- 2. Recogn'zes that physicians have primary responsibility for protection of their patients, by stating that the NRC will not intrude into medical judgements forming the basis of the physicians' prescription.
- 3. Regulation of the radiation safety of patients is risk based.
CODE
- 1. NRC's role in regulating the radiation safety of patients is narrowly focused.
4
_=